Literature DB >> 21464596

Antiviral activity of methylelaiophylin, an alpha-glucosidase inhibitor.

Doseung Lee1, Jin-Kyu Woo, Donghern Kim, Minyoung Kim, Somi K Cho, Jae Hoon Kim, Se Pill Park, Hyo Yeon Lee, Key Zung Riu, Dong-Sun Lee.   

Abstract

Methylelaiophylin isolated from Streptomyces melanosporofaciens was selected as an alpha-glucosidase inhibitor with an IC50 value of 10 micrometer. It showed mixedtype inhibition of alpha-glucosidase with a Ki value of 5.94 micrometer. In addition, methylelaiophylin inhibited the intracellular trafficking of hemagglutinin-neuramidase (HN), a glycoprotein of Newcastle disease virus (NDV), in baby hamster kidney (BHK) cells. Methylelaiophylin inhibited the cell surface expression of NDV-HN glycoprotein without significantly affecting HN glycoprotein synthesis in NDV-infected BHK cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464596

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  4 in total

1.  Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.

Authors:  Haet Nim Lim; Jun-Pil Jang; Jang Mi Han; Jae-Hyuk Jang; Jong Seog Ahn; Hye Jin Jung
Journal:  Molecules       Date:  2018-03-02       Impact factor: 4.411

2.  Efomycins K and L From a Termite-Associated Streptomyces sp. M56 and Their Putative Biosynthetic Origin.

Authors:  Jonathan L Klassen; Seoung Rak Lee; Michael Poulsen; Christine Beemelmanns; Ki Hyun Kim
Journal:  Front Microbiol       Date:  2019-08-06       Impact factor: 5.640

Review 3.  Natural Occurrence, Bioactivity and Biosynthesis of Elaiophylin Analogues.

Authors:  Min Gui; Meng-Xue Zhang; Wen-Hui Wu; Peng Sun
Journal:  Molecules       Date:  2019-10-25       Impact factor: 4.411

Review 4.  Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.

Authors:  Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2013-06-29       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.